Sep 26, 2022 | Covid-19, News
By Julie Steenhuysen CHICAGO, Sept 22 (Reuters) – People who had COVID-19 are at higher risk for a host of brain injuries a year later compared with people who were never infected by the coronavirus, a finding that could affect millions of Americans, U.S.... 
Sep 26, 2022 | Covid-19, News
The first large, real-world study of the effectiveness of mRNA COVID-19 vaccines during pregnancy found these vaccines, especially two initial doses followed by a booster, are effective in protecting against serious disease in expectant mothers whether the shots are... 
Sep 20, 2022 | Covid-19, News
The new bivalent (two-strain) Moderna COVID-19 vaccine booster triggered stronger neutralizing antibody responses against the highly transmissible Omicron variant at 28 days than the previously authorized booster, with no safety concerns, according to the interim... 
Sep 20, 2022 | Covid-19, News
Scientists have created a face mask that can detect common respiratory viruses, including influenza and the coronavirus, in the air in droplets or aerosols. The highly sensitive mask, presented September 19 in the journal Matter, can alert the wearers via their mobile... 
Sep 13, 2022 | Covid-19, News
COVID-19 patients who had received two doses of the Pfizer/BioNTech vaccine reported 8 of the 10 most common long-COVID symptoms 50% to 80% less often than their unvaccinated counterparts, finds an ongoing Israeli study published in the Nature journal npj Vaccines. A... 
Sep 6, 2022 | Covid-19, News
For almost three years, scientists have raced to understand the immune responses in patients who develop severe COVID-19, with an enormous effort aimed at defining where healthy immunity ends and destructive immunity begins. In the early days of the COVID-19 pandemic,...
